The global sugar coated tablets industry is expected to grow from US$ 15.2 billion in 2023 to US$ 27.5 billion by 2030, at a CAGR of 10.5% during the forecast period. The growth of the market is attributed to the increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory diseases, which require long-term medication. Sugar coated tablets are a popular dosage form for these medications, as they are easy to swallow and have a pleasant taste.

Sugar-coated tablets are a type of solid dosage form in which the tablet core is coated with a layer of sugar. Sugar coating is a traditional pharmaceutical process that has been used for over 100 years to improve the taste, appearance, and stability of tablets.

To Get the Sample Copy of Report Visit! https://absolutemarketresearch.com/Global-Sugar-Coated-Tablets-Market/2255/request-sample

Global Sugar Coated Tablets Industry Regional Outlook:

North America:

North America is the largest market for sugar coated tablets, accounting for over 35% of the global market share in 2023. The market growth in this region is attributed to the increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular diseases. Additionally, the rising demand for sugar-free and chewable tablets is also driving the market growth.

Europe:

Europe is the second-largest market for sugar coated tablets, accounting for over 25% of the global market share in 2023. The market growth in this region is driven by the increasing aging population and the rising demand for over-the-counter (OTC) drugs. Additionally, the growing awareness of the benefits of sugar-free and chewable tablets is also fueling the market growth.

Asia Pacific:

Asia Pacific is the fastest-growing market for sugar coated tablets, with a CAGR of over 11% during the forecast period. The market growth in this region is attributed to the increasing population, rising disposable incomes, and growing awareness of the benefits of sugar-free and chewable tablets. Additionally, the rising prevalence of chronic diseases, such as diabetes and obesity, is also driving the market growth.

Latin America:

Latin America is a significant market for sugar coated tablets, with a market share of over 10% in 2023. The market growth in this region is attributed to the increasing population, rising disposable incomes, and growing awareness of the benefits of sugar-free and chewable tablets. Additionally, the rising prevalence of chronic diseases, such as diabetes and obesity, is also driving the market growth.

Middle East and Africa:

The Middle East and Africa is a small market for sugar coated tablets, with a market share of less than 5% in 2023. However, the market is expected to grow at a significant CAGR during the forecast period. The market growth in this region is attributed to the increasing population, rising disposable incomes, and growing awareness of the benefits of sugar-free and chewable tablets. Additionally, the rising prevalence of chronic diseases, such as diabetes and obesity, is also driving the market growth.

Key Takeaways:

  • The global sugar coated tablets market is expected to grow from US$ 15.2 billion in 2023 to US$ 27.5 billion by 2030, at a CAGR of 10.5%.
  • The growth of the market is attributed to the increasing prevalence of chronic diseases, rising demand for convenient and easy-to-consume dosage forms, and growing awareness about the benefits of sugar coated tablets.
  • The Asia Pacific region is expected to be the fastest-growing market during the forecast period, owing to the increasing population, rising disposable incomes, and growing awareness about the benefits of sugar coated tablets.

Global Sugar Coated Tablets Industry Key Players:

  • Boehringer Ingelheim
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Novartis
  • Sanofi
  • Johnson & Johnson
  • Merck
  • Abbott Laboratories
  • Eli Lilly and Company
  • AstraZeneca

Global Sugar Coated Tablets Industry Segmentation:

Type:

  • Hard Coated Tablets
  • Soft Coated Tablets

Application:

  • Prescription Drugs
  • Over-the-Counter Drugs

Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa